Welcome to Medications.com

Acorda Sinks on Forecast Wider 2008 Loss - Forbes

In the same SEC filing, Acorda said it expects to post a loss of $14 million during the fourth quarter, as sales of the muscle relaxant Zanaflex reached $12 ...

http://www.forbes.com/feeds/ap/20... | Posted: Wed Feb 06 19:03:49 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea